Novo GlucaGen Launch For Hypoglycemia Awaits Co-Marketing Agreement
Novo Nordisk will launch its recombinant DNA glucagon product GlucaGen only after it has found a co-marketing partner, the company said following approval June 22.
Novo Nordisk will launch its recombinant DNA glucagon product GlucaGen only after it has found a co-marketing partner, the company said following approval June 22.